Author

V. Vollenweider

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:drug response / drug discovery· 1 Organism:E. coli· 1 Organism:human· 1 Research Focus:perturbation response prediction· 1 Assay:proteomics· 1

Frequent Co-Authors

R. Kuemmerli· 2 shared C. Chepkirui· 1 shared F. Roncoroni· 1 shared J. Piel· 1 shared K. Rehm· 1 shared L. Bigler· 1 shared M. Perez-Berlanga· 1 shared M. Polymenidou· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

R. Kuemmerli

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Pyoverdine-antibiotic combination treatment: its efficacy and effects on resistance evolution in Escherichia coli

V. Vollenweider, F. Roncoroni, R. Kuemmerli

This study examines how pyoverdine and ceftazidime interact with E. coli resistance evolution, showing combination treatment reduces resistance development.

bioRxiv · Apr 17, 2024 · PreprintMicrobiology

Antimicrobial activity of iron-depriving pyoverdines against human opportunistic pathogens

V. Vollenweider, K. Rehm, C. Chepkirui, M. Perez-Berlanga, M. Polymenidou, J. Piel, L. Bigler, R. Kuemmerli

This study identifies pyoverdines from Pseudomonas spp. as potent antibacterials against human pathogens by inducing iron starvation, showing reduced resistance potential compared to antibiotics.

bioRxiv · Jul 18, 2023Microbiology